Asia-Pacific Injectable Drug Delivery Market Analysis, By Device Type (Self-injection Devices, Conventional Devices), By Formulation (Conventional Drug Delivery, Novel Drug Delivery), By Therapeutic Use (Autoimmune Disorders, Hormonal Disorders, Oncology), By End-user (Hospitals, Homecare Settings, Research Institutes, Clinical Laboratories), By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

Asia-Pacific Injectable Drug Delivery Market Analysis, By Device Type (Self-injection Devices, Conventional Devices), By Formulation (Conventional Drug Delivery, Novel Drug Delivery), By Therapeutic Use (Autoimmune Disorders, Hormonal Disorders, Oncology), By End-user (Hospitals, Homecare Settings, Research Institutes, Clinical Laboratories), By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

ID: 2111 | Pages: 130 | May 2017 | Region: Asia Pacific


The Asia-Pacific Injectable Drug Delivery Market was worth USD 83.35 billion in 2016 and estimated to be growing at a CAGR of 12.15%, to reach 147.87 billion by 2021

Injectable drug delivery is characterized as introduction of a drug or drugs in the patient by utilizing a delivery device. Injectables permit the transport of drug in fluid form, directly into the body.

The key factors driving the development of injectables are increase in the cases of cancer and diabetic patients, enhanced patient consistence to drug delivery system and advancement in technology. The key limiting factors that affect the development of injectables market incorporate injuries caused while administering injectables, patient safety issues, advancement of substitute drug delivery methods and product reviews.

Injectable Drug Delivery Market is segmented into Device Type, Formulation, Therapeutic Use, End-user, Region. On the basis of Device type, the market is segmented into Self-Injection Devices, Conventional Devices. On the basis of Formulation, the market is segmented into Conventional Drug Delivery, Novel Drug Delivery. On the basis of Therapeutic Use, market is divided into Autoimmune Disorders, Hormonal Disorders, Oncology. On the basis of end user, the market is further divided into Hospitals, Homecare Settings, Research Institutes, Clinical Laboratories. On the basis of geography, the Asia-Pacific market is analyzed under various regions namely Japan, China, Australia, India and South Korea. The developing Asian and Latin America nations collectively represent to the fastest developing business sector for injectables because of the increase in occurrences of disease and diabetes in patients and furthermore their consistence to novel advancements. Besides, the drug and device manufacturers are concentrating on major rising injectables market of Asia and Asia-Pacific because of less stringent directions for obtaining approvals on less competition and devices.

Some of the major companies dominating the market, by their products and services include Antares Pharmaceuticals Ltd, Baxter International, Becton Dickinson Company, Elcam Medical, Eli Lily and Company, Unilife Corporation and West Pharmaceutical Inc.

1.Introduction                                                                  

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 Epidemology                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Device Type                                                               

                                5.1.1 Introduction                                           

                                5.1.2 Self-injection Devices                                         

                                5.1.3  Conventional Devices                                        

                                5.1.4  Y-o-Y Growth Analysis, By Device Type                                      

                                5.1.5  Market Attractiveness Analysis, By Device Type                                    

                                5.1.6  Market Share Analysis, By Device Type                                     

                5.2 Formulation                                                               

                                5.2.1 Introduction                                           

                                5.2.2 Conventional Drug Delivery                                             

                                5.2.3  Novel Drug Delivery                                           

                                5.2.4 Y-o-Y Growth Analysis, By Formulation                                       

                                5.2.5 Market Attractiveness Analysis, By Formulation                                     

                                5.2.6 Market Share Analysis, By Formulation                                      

                5.3 Therapeutic Use                                                       

                                5.3.1 Introduction                                           

                                5.3.2 Autoimmune Disorders                                     

                                5.3.3 Hormonal Disorders                                            

                                5.3.4 Oncology                                 

                                5.3.5 Y-o-Y Growth Analysis, By Therapeutic Use                                              

                                5.3.6  Market Attractiveness Analysis, By Therapeutic Use                                           

                                5.3.7  Market Share Analysis, By Therapeutic Use                                             

                5.4 End-user

                                5.4.1 Introduction                                           

                                5.4.2 Hospitals                                  

                                5.4.3 Homecare Settings                                              

                                5.4.4 Research Institutes                                             

                                5.4.5 Clinical Laboratories                                            

                                5.4.6 Other                                        

                                5.4.7 Y-o-Y Growth Analysis, By End-user

                                5.4.8  Market Attractiveness Analysis, By End-user

                                5.4.9  Market Share Analysis, By End-user

6. Geographical Analysis                                                                              

                6.1 Introduction                                                               

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                                6.1.3.1 By Geographical Area                     

                                                6.1.3.2 By Device Type                  

                                                6.1.3.3 By Formulation                  

                                                6.1.3.4 By Therapeutic Use                         

                                                6.1.3.5 By End-user

                                6.1.4  Market Attractiveness Analysis                                     

                                                6.1.4.1 By Geographical Area                     

                                                6.1.4.2 By Device Type                  

                                                6.1.4.3 By Formulation                  

                                                6.1.4.4 By Therapeutic Use                         

                                                6.1.4.5 By End-user

                                6.1.5  Market Share Analysis                                      

                                                6.1.5.1 By Geographical Area                     

                                                6.1.5.2 By Device Type                  

                                                6.1.5.3 By Formulation                  

                                                6.1.5.4 By Therapeutic Use                         

                                                6.1.5.5 By End-user

                6.2 China                                                             

                6.3 India                                                              

                6.4 Japan                                                            

                6.5 South Korea                                                               

                6.6 Australia                                                      

7.Strategic Analysis                                                                        

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8.Market Leaders' Analysis                                                                         

                8.1 Alkermes Inc.                                                            

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Bend Research                                                          

                8.3 BIND Biosciences Inc.                                                             

                8.4 Endocyte                                                     

                8.5 Genentech Inc.                                                         

                8.6 MicroCHIPS Inc.                                                        

                8.7 Pearl Therapeutics Inc.                                                          

                8.8 Polymer Factory                                                       

                8.9 Presage Bioscience                                                 

                8.10  QLT Inc.                                                     

                8.11 UCB Group.                                                              

9.Competitive Landscape                                                                            

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10.Market Outlook and Investment Opportunities                                                                          

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia-Pacific Injectable Drug Delivery Market By Device Type , From 2016-2021 ( USD Million )
  2. Asia-Pacific Self-injection Devices Market By Region, From 2016-2021 ( USD Million )
  3. Asia-Pacific Conventional Devices Market By Region, From 2016-2021 ( USD Million )
  4. Asia-Pacific Injectable Drug Delivery Market By Formulation, From 2016-2021 ( USD Million )
  5. Asia-Pacific Conventional Drug Delivery Market By Region, From 2016-2021 ( USD Million )
  6. Asia-Pacific Novel Drug Delivery Market By Region, From 2016-2021 ( USD Million )
  7. Asia-Pacific Injectable Drug Delivery Market By Therapeutic Use, From 2016-2021 ( USD Million )
  8. Asia-Pacific Autoimmune Disorders Market By Region, From 2016-2021 ( USD Million )
  9. Asia-Pacific Hormonal Disorders Market By Region, From 2016-2021 ( USD Million )
  10. Asia-Pacific Oncology Market By Region, From 2016-2021 ( USD Million )
  11. Asia-Pacific Injectable Drug Delivery Market By End-user, From 2016-2021 ( USD Million )
  12. Asia-Pacific Hospitals Market By Region, From 2016-2021 ( USD Million )
  13. Asia-Pacific Homecare Settings Market By Region, From 2016-2021 ( USD Million )
  14. Asia-Pacific Research Institutes Market By Region, From 2016-2021 ( USD Million )
  15. Asia-Pacific Clinical Laboratories Market By Region, From 2016-2021 ( USD Million )
  16. Japan Injectable Drug Delivery Market By Device Type , From 2016-2021 ( USD Million )
  17. Japan Injectable Drug Delivery Market By Formulation, From 2016-2021 ( USD Million )
  18. Japan Injectable Drug Delivery Market By Therapeutic Use, From 2016-2021 ( USD Million )
  19. Japan Injectable Drug Delivery Market By End-user, From 2016-2021 ( USD Million )
  20. China Injectable Drug Delivery Market By Device Type , From 2016-2021 ( USD Million )
  21. China Injectable Drug Delivery Market By Formulation, From 2016-2021 ( USD Million )
  22. China Injectable Drug Delivery Market By Therapeutic Use, From 2016-2021 ( USD Million )
  23. China Injectable Drug Delivery Market By End-user, From 2016-2021 ( USD Million )
  24. India Injectable Drug Delivery Market By Device Type , From 2016-2021 ( USD Million )
  25. India Injectable Drug Delivery Market By Formulation, From 2016-2021 ( USD Million )
  26. India Injectable Drug Delivery Market By Therapeutic Use, From 2016-2021 ( USD Million )
  27. India Injectable Drug Delivery Market By End-user, From 2016-2021 ( USD Million )
  28. Australia Injectable Drug Delivery Market By Device Type , From 2016-2021 ( USD Million )
  29. Australia Injectable Drug Delivery Market By Formulation, From 2016-2021 ( USD Million )
  30. Australia Injectable Drug Delivery Market By Therapeutic Use, From 2016-2021 ( USD Million )
  31. Australia Injectable Drug Delivery Market By End-user, From 2016-2021 ( USD Million )
  32. South Korea Injectable Drug Delivery Market By Device Type , From 2016-2021 ( USD Million )
  33. South Korea Injectable Drug Delivery Market By Formulation, From 2016-2021 ( USD Million )
  34. South Korea Injectable Drug Delivery Market By Therapeutic Use, From 2016-2021 ( USD Million )
  35. South Korea Injectable Drug Delivery Market By End-user, From 2016-2021 ( USD Million )
Middle East And Africa Parkinson’s Disease Treatment Market By Drug Class (Dopamine Receptor Antagonists, Mono Amine Oxidase Inhibitors, Carbidopa, Anticholinergics And Other Drug Classes), By Distribution Channel...
Latin America Parkinson’s Disease Treatment Market By Drug Class (Dopamine Receptor Antagonists, Mono Amine Oxidase Inhibitors, Carbidopa, Anticholinergics And Other Drug Classes), By Distribution Channel (Retaile...
Asia Pacific Parkinson’s Disease Treatment Market By Drug Class (Dopamine Receptor Antagonists, Mono Amine Oxidase Inhibitors, Carbidopa, Anticholinergics And Other Drug Classes), By Distribution Channel (Retailer...
Europe Parkinson’s Disease Treatment Market By Drug Class (Dopamine Receptor Antagonists, Mono Amine Oxidase Inhibitors, Carbidopa, Anticholinergics And Other Drug Classes), By Distribution Channel (Retailer Pharm...
North America Parkinson’s Disease Treatment Market By Drug Class (Dopamine Receptor Antagonists, Mono Amine Oxidase Inhibitors, Carbidopa, Anticholinergics And Other Drug Classes), By Distribution Channel (Retaile...
Parkinson’s Disease Treatment Market By Drug Class (Dopamine Receptor Antagonists, Mono Amine Oxidase Inhibitors, Carbidopa, Anticholinergics And Other Drug Classes), By Distribution Channel (Retailer Pharmacies, ...
Middle East And Africa Intraoperative Imaging Market By Product (Mobile C-arms, CT, Intraoperative MRI, Intraoperative Ultrasound), By Application (Neurosurgery, Orthopedic, Trauma, Spine Surgery, Cardiovascular, E...
Latin America Intraoperative Imaging Market By Product (Mobile C-arms, CT, Intraoperative MRI, Intraoperative Ultrasound), By Application (Neurosurgery, Orthopedic, Trauma, Spine Surgery, Cardiovascular, ENT, Gastr...
Asia Pacific Intraoperative Imaging Market By Product (Mobile C-arms, CT, Intraoperative MRI, Intraoperative Ultrasound), By Application (Neurosurgery, Orthopedic, Trauma, Spine Surgery, Cardiovascular, ENT, Gastro...
Europe Intraoperative Imaging Market By Product (Mobile C-arms, CT, Intraoperative MRI, Intraoperative Ultrasound), By Application (Neurosurgery, Orthopedic, Trauma, Spine Surgery, Cardiovascular, ENT, Gastro, Maxi...
North America Intraoperative Imaging Market By Product (Mobile C-arms, CT, Intraoperative MRI, Intraoperative Ultrasound), By Application (Neurosurgery, Orthopedic, Trauma, Spine Surgery, Cardiovascular, ENT, Gastr...
Intraoperative Imaging Market By Product (Mobile C-arms, CT, Intraoperative MRI, Intraoperative Ultrasound), By Application (Neurosurgery, Orthopedic, Trauma, Spine Surgery, Cardiovascular, ENT, Gastro, Maxillofaci...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.